Johannes Holert, Rudolf Wilhelm, Jens Henker, Claudia A. Reinker, Franziska M. Müller, Bodo Philipp
{"title":"Chicken Manure as a Sustainable Bile Acid Source for Biotechnological Applications","authors":"Johannes Holert, Rudolf Wilhelm, Jens Henker, Claudia A. Reinker, Franziska M. Müller, Bodo Philipp","doi":"10.1111/1751-7915.70178","DOIUrl":null,"url":null,"abstract":"<p>Ursodeoxycholic acid (UDCA) is widely administered to dissolve gallstones, treat liver disorders and reduce blood cholesterol levels. This study investigated fresh and dried chicken manure as a sustainable bioresource for chenodeoxycholic acid (CDCA), a precursor for the biotechnological production of UDCA. For this, bile acids from five commercial dried and seven fresh chicken manure samples were analysed. The bile acid pool consisted predominantly of CDCA (30%–90%) and 7-keto lithocholic acid (7k-LCA, 8%–56%), with minor amounts of cholic acid. CDCA concentrations varied between 62 and 2990 mg per kg dry weight, and the highest concentrations were found in two samples from fresh chicken manure, confirming that chickens can produce high but varying amounts of faecal CDCA. As a proof of principle, a newly created <i>Pseudomonas putida</i> KT2440 strain expressing a heterologous 7α−/7β-hydroxysteroid dehydrogenase system was shown to be able to transform manure-derived CDCA into UDCA without prior substrate purification from raw ethanolic chicken manure extracts. These results demonstrate that chicken manure can be used as an untapped resource for bile acids for biotechnological applications, providing a novel approach for the valorisation of this bioresource.</p>","PeriodicalId":209,"journal":{"name":"Microbial Biotechnology","volume":"18 6","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.70178","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.70178","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Ursodeoxycholic acid (UDCA) is widely administered to dissolve gallstones, treat liver disorders and reduce blood cholesterol levels. This study investigated fresh and dried chicken manure as a sustainable bioresource for chenodeoxycholic acid (CDCA), a precursor for the biotechnological production of UDCA. For this, bile acids from five commercial dried and seven fresh chicken manure samples were analysed. The bile acid pool consisted predominantly of CDCA (30%–90%) and 7-keto lithocholic acid (7k-LCA, 8%–56%), with minor amounts of cholic acid. CDCA concentrations varied between 62 and 2990 mg per kg dry weight, and the highest concentrations were found in two samples from fresh chicken manure, confirming that chickens can produce high but varying amounts of faecal CDCA. As a proof of principle, a newly created Pseudomonas putida KT2440 strain expressing a heterologous 7α−/7β-hydroxysteroid dehydrogenase system was shown to be able to transform manure-derived CDCA into UDCA without prior substrate purification from raw ethanolic chicken manure extracts. These results demonstrate that chicken manure can be used as an untapped resource for bile acids for biotechnological applications, providing a novel approach for the valorisation of this bioresource.
期刊介绍:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry; Primary metabolites; Food, beverages and supplements; Secondary metabolites and natural products; Pharmaceuticals; Diagnostics; Agriculture; Bioenergy; Biomining, including oil recovery and processing; Bioremediation; Biopolymers, biomaterials; Bionanotechnology; Biosurfactants and bioemulsifiers; Compatible solutes and bioprotectants; Biosensors, monitoring systems, quantitative microbial risk assessment; Technology development; Protein engineering; Functional genomics; Metabolic engineering; Metabolic design; Systems analysis, modelling; Process engineering; Biologically-based analytical methods; Microbially-based strategies in public health; Microbially-based strategies to influence global processes